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INVITED COMMENTARY
Thomas Lynch, MD, Washington, D.C.
Woo et al suggest that evidence-based guidelines for hemodialysis access are based on population data rather than patient-level data and that clinical practice guidelines offer general recommendations that may not be actionable on an individual patient level. To that point, population health is defined as ".the health outcomes of a group of individuals, including the distribution of such outcomes within the group," 1 suggesting variation across the population. Although population health was initially used to define the health of geographic populations, population health management and population management are now used to describe activities focused on more medically specific clinical populations. In addressing population health management (in this case end-stage kidney disease in patients on hemodialysis access), the increasing challenge is to balance the unique needs of the individual patient with the evidence-based optimal management of the population. 2 As the authors have suggested, a multitude of characteristics may influence the outcome of the access procedure, including gender, race, age, medical comorbidities, vascular anatomy, obesity, and socioeconomic status. The business literature would tell us that we need to be careful setting and rewarding performance metrics. Foremost, it must be remembered that a performance metric is not a goal. It is a means to an end and should not become the goal. The Centers for Medicare and Medicaid Services established a target of 66% arteriovenous fistulas in the hemodialysis population. This is a population-based performance metric; the goal is to provide optimal hemodialysis access for each patient with end-stage kidney disease.
In his article, "On the folly of rewarding A, while hoping for B," 3 
Steven Kerr cautions that individuals seek to know
what is rewarded and then do those things to the exclusion of activities not rewarded. He writes that establishing simple, quantifiable metrics with which to reward performance may be successful in highly predictable areas but are likely to cause "goal displacement" when applied to decisions dependent on more complex assessments with multiple variables; in the case of hemodialysis access, those variables would include patient demographics, anatomy, and comorbidities. Likierman 4 and Ordóñez et al 5 have expressed similar concerns. They caution that metrics can cause people to narrow their focus and that such intense focus can obscure important issues that may seem unrelated to the ultimate goal. Metrics are only proxies for performance. As Woo et al suggest, patient-specific circumstances exist where arteriovenous fistulas may not be the best option for a patient. Let's be careful not to lose the patient for the population and the ultimate goal of a functional access, free of complications and interventions, as we set performance metrics and their rewards.
